Analysis of pathogenic genes in dengue virus

Abstract

Dengue virus (DENV) remains a significant global health threat, presenting intricate challenges in its epidemiology, vector control, and the quest for effective vaccines and treatments. The challenges encompass the complex epidemiology marked by four serotypes, difficulties in vector control, and the ongoing pursuit of a universally effective vaccine. Antiviral therapeutics tailored to DENV are also under exploration. Despite these challenges, advancements in vaccine development, innovative vector control strategies, and precision medicine offer promising avenues for future management. Early warning systems and digital health technologies stand out as transformative tools for surveillance and clinical management. Global collaboration, community engagement, and climate-resilient approaches are identified as crucial elements for sustained Dengue control.